Lyell Immunopharma H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 South San Francisco, CA HQ🌐 lyell.com
Does Lyell Immunopharma sponsor H-1B visas and green cards?
Yes. Lyell Immunopharma has filed 22 H-1B LCAs and 3 PERM green-card cases with the U.S. Department of Labor between FY2019 and FY2026. In FY2025–2026 Lyell Immunopharma filed 3 H-1B LCAs at a median base salary of $160,169, about 31% above the national H-1B median of $121,966 for the same period. 2 green-card cases were decided in FY2023.
South San Francisco, CA accounts for 77% of its H-1B filings.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 1 | $291k |
| FY2025 | 2 | $152k |
| FY2024 | 2 | $177k |
| FY2023 | 3 | $196k |
| FY2022 | 5 | $160k |
| FY2021 | 4 | $267k |
| FY2020 | 3 | $165k |
| FY2019 | 2 | $176k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
- 1Sr. Director of Total Rewards4$267k
- 2Senior Business Analyst, Financial Systems3$165k
- 3Senior Scientist, Translational Pathology Laboratory2$155k
- 4Sr. Business Analyst, Financial Systems2$161k
- 5Sr. Director, Total Rewards2$237k
- 6Associate Director Regulatory1$198k
- 7Clinical Data Platform Product Manager1$200k
- 8Computational Biologist, Sr.1$111k
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2023 | 2 | $213k |
| FY2021 | 1 | $116k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 5
- US patents
- Published, not yet granted
- 22
- applications
- Most recent grant
- July 22, 2025
- Top area
- Microorganisms or enzymes; compositions thereof; propagating3
Pay against the local market
Lyell Immunopharma’s 10 most-filed occupations and metros, FY2019–FY2026. Its median base salary is 129% of the local BLS median for the same work.
| Occupation | Metro | Filings | Lyell Immunopharma pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Compensation and Benefits Managers | San Francisco, CA | 6 | $252,427 | $166,693 | 151% |
| Biological Scientists, All Other | San Francisco, CA | 4 | $136,626 | $115,635 | 118% |
| Computer Systems Analysts | San Francisco, CA | 3 | $162,122 | $137,257 | 118% |
| Computer Systems Analysts | Seattle, WA | 2 | $165,000 | $110,290 | 150% |
| Medical Scientists | San Francisco, CA | 2 | $154,500 | $138,595 | 111% |
| Managers, All Other | San Francisco, CA | 1 | $197,600 | $192,670 | 103% |
| Accountants and Auditors | San Francisco, CA | 1 | $160,000 | $100,450 | 159% |
| Managers, All Other | Seattle, WA | 1 | $133,000 | $156,060 | 85% |
| Computer and Information Systems Managers | Seattle, WA | 1 | $200,000 | $212,450 | 94% |
| Natural Sciences Managers | San Francisco, CA | 1 | $291,304 | $222,840 | 131% |
About Lyell Immunopharma
- Legal name
- Lyell Immunopharma, Inc.
- Listed
- Nasdaq: LYEL
- Incorporated in
- Delaware
- Headquarters
- 201 Haskins Way, South San Francisco, CA 94080
- Industry
- Pharma & biotech
- Employees (US, est)
- 200 (2024)
- Revenue FY2025
- $0M -41% from $0M
- Net income FY2025
- $-274M +20% from $-343M
- R&D FY2025
- $159M (440764% of revenue)
H-1B sponsors similar to Lyell Immunopharma
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Raritan Pharmaceuticals | 24 | 3 | $115k | 0 | — |
| uniQure | 24 | 3 | $167k | 1 | — |
| Axbio | 24 | 2 | $116k | 0 | — |
| Lyell Immunopharma | 22 | 3 | $160k | 0 | — |
| Dr. Reddy's Laboratories | 22 | 1 | $305k | 0 | — |
| Alloy Therapeutics | 22 | 5 | $113k | 2 | — |
| Ampion, PBC | 22 | 12 | $80k | 1 | — |
